FNY Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76K Sell
596
-304
-34% -$35.6K 0.03% 358
2026
Q1
$108K Sell
900
-9,300
-91% -$1.07M 0.05% 267
2025
Q4
$1.07M Buy
+10,200
New +$957K 0.3% 79
2025
Q2
Sell
-2,500
Closed -$224K 1103
2025
Q1
$224K Buy
+2,500
New +$233K 0.14% 142
2024
Q3
Sell
-22,500
Closed -$2.79M 758
2024
Q2
$2.79M Buy
22,500
+15,350
+215% +$1.98M 1.87% 8
2024
Q1
$943 Buy
+7,150
New +$881K 0.57% 44
2018
Q4
Sell
-1,572
Closed -$106K 895
2018
Q3
$106K Buy
+1,572
New +$100K 0.02% 265

Other funds holding MRK

FNY Investment Advisers's MRK Position: Q2 2026 in Review

FNY Investment Advisers reduced its Merck (MRK) stake by 34% in Q2 2026, selling an estimated $35.6K and leaving 596 shares worth $76K. The position accounts for 0.03% of the portfolio, ranked #358.

FNY Investment Advisers first reported a position in MRK in Q3 2018 and has held it in 7 quarters since. The position peaked at $2.79M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FNY Investment Advisers held 596 shares of Merck worth $76K as of Q2 2026.
  • FNY Investment Advisers sold 304 Merck shares in Q2 2026, an estimated $35.6K.
  • Merck made up 0.03% of FNY Investment Advisers's portfolio in Q2 2026, its #358 holding.
  • FNY Investment Advisers first reported a position in Merck in Q3 2018 and has held it in 7 quarters since.
  • FNY Investment Advisers's Merck position peaked at $2.79M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.